Stockhouse2h
Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
Tokyo, Japan and Cambridge, UK, 2 September 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of XPEL
If you suffered losses exceeding $100,000 investing in XPEL stock or options between November 8, 2023 and May 2, 2024 and ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna
If you suffered losses exceeding $100,000 in Moderna between January 18, 2023 and June 25, 2024 and would like to discuss ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Extreme Networks
If you suffered losses exceeding $100,000 in Extreme Networks between July 27, 2022 and January 30, 2024 and would like to ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Symbotic
If you suffered losses exceeding $100,000 in Symbotic between May 6, 2024 and July 29, 2024 and would like to discuss your ...
Shareholders that lost money on Super Micro Computer, Inc.(SMCI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NDAQ:SMCI) Shareholders that lost money on Super Micro Computer, Inc.(SMCI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More ...